Shiraz Institute for Cancer Research, opened in June 1998, is located on Shiraz School of medicine main campus at Zand Avenue. The institute is the first nation’s comprehensive center in which both immunological and biological aspects of cancer are under investigation.
Read more about us

Feature Slides

Our affiliation

Shiraz Institute for Cancer Research (ICR)
School of Medicine
Shiraz University of Medical Sciences
P.O. Box: 71345-3119
Useful links




Call for grant

Interested academics and post-graduated students are
requested to visit the following website for grant application:

Postdoctoral Research Fellowship

Up to two postdoctoral fellows are now available at Shiraz Institute for Cancer Research under supervision of Dr. Ghaderi, ICR director. For more information, please contact to Dr. Ghaderi at

Journal Clubs and Seminars

The journal clubs or seminars meet regularly every two weeks for one hour, 8:30-9:30 A.M. on Sunday in lecture room, to review current research about clinical practice especially in the field of cancer research. ...

Highly cited papers

1. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. (51 citations)
2. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express .... (31 citations)
3. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in Rabbit (26 citations)
4. CTLA4 gene variants in autoimmunity and cancer: A comparative review. (20 citations)
5. IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers (18 citations)

New publications

1. Sanaee MN, Malekzadeh M, Khezri A, Ghaderi A, Doroudchi M. Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer. Urologia internationalis. 2015;94(4):472-8.

2. Rezaeifard S, Razmkhah M, Robati M, Momtahan M, Ghaderi A. Cytokines, chemokines, and chemokine receptors quantitative expressions in patients with ovarian cancer. Iranian journal of medical sciences. 2015;40(3):225-32.

3. Razmkhah M, Abedi N, Hosseini A, Imani MT, Talei AR, Ghaderi A. Induction of T Regulatory Subsets from Naive CD4+ T Cells after Exposure to Breast Cancer Adipose Derived Stem Cells. Iranian journal of immunology : IJI. 2015;12(1):1-15.

4. Nemati K, Golmoghaddam H, Hosseini SV, Ghaderi A, Doroudchi M. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression. Gene. 2015;561(1):88-94.

5. Namazi S, Sahebi E, Rostami-Yalmeh J, Jaberipour M, Razmkhah M, Hosseini A, et al. Effect of angiotensin receptor blockade on prevention and reversion of tamoxifen-resistant phenotype in MCF-7 cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36(2):893-900.


 Find all published papers here...



Breast cancer congress
28-30 October 2015, Tehran, Iran
Journal club on 26th Farvardin
Cell therapy in cancer
4th European Congress of Immunology (ECI);Vienna 2015
6-9 September 2015 in Vienna. Abstract deadline of 30 April 2015
Seminar on 13th Bahman
Tolerogenic DC and Cancer
Seminar on 22th Day
An introduction to "T stem cell memory: TSCM"
Seminar on 17th Day
CRISPR-Cas9 as a versatile tool for genome engineering
10th International Congress of Breast Cancer